Aralez Reports Fourth Quarter And Full-Year 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff pulls Wall Street to two-week lows as oil and yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- Tech selloff pulls Wall Street to two-week lows as oil and yields climb
Aralez Pharma (ARLZ) Reports Q4 Loss of $0.48/Share
March 13, 2017 6:48 AM EDTAralez Pharma (NASDAQ: ARLZ) reported Q4 EPS of ($0.48), versus ($0.40) reported last year. Revenue for the quarter came in at $20 million, versus $6 million reported last year.
GUIDANCE:
Aralez Pharma sees FY2017 revenue of $80-100 million.
For earnings history and earnings-related data on Aralez Pharma (ARLZ) click here.
... More